Internal SpaceX Documents Reveal Sweet Deals for Top Investorsby Mark Eisenberg 20.06.2024Discover how SpaceX allows employees and key investors to benefit from stock deals, revealing insider details on pricing, shares, and ...
Coupang Director Sells $14.44M in Stock Amid Growthby Mark Eisenberg 18.06.2024"Coupang Director Benjamin Sun sells $14.44M in stock, signaling optimism despite challenges. Q1 2024 shows 33% revenue rise, boosting investor ...
Alignment Healthcare Director Sells Shares, Ups Price Targetby Mark Eisenberg 18.06.2024"Jeffrey H. Margolis of Alignment Healthcare sells 1,200 shares worth $9,672. Despite insider sale, company sees 50% membership increase."
After-Hours Movers: NextEra, Lennar, La-Z-Boy, Chegg Soarby Mark Eisenberg 18.06.2024"After-hours movers: La-Z-Boy and Chegg soar on strong earnings and plans, while NextEra Energy and Lennar Corp. see declines despite ...
Brighthouse Financial Upgraded; Price Target Loweredby Terry Bingman 17.06.2024Brighthouse Financial’s stock rating shifted as Piper Sandler cut its price target from $55.00 to $50.00, citing earnings concerns.
Fisher Investments: $3B Strategic Partnership with Advent, ADIAby Mark Eisenberg 16.06.2024Advent and ADIA invest $2.5-$3B, valuing Fisher Investments at $12.75B. Founder Ken Fisher sells holdings. New board member: Advent's Mussafer.
Madrigal Pharma Exec Sells $570K in Stock Amid Analyst Focusby Mark Eisenberg 15.06.2024Waltermire sells 2,000 shares at $285 each, netting $570K; Madrigal Pharmaceuticals sees mixed analyst reports with H.C. Wainwright lowering its ...
Prairie Operating’s Stephen Lee Sells $6,977 in Sharesby Mark Eisenberg 15.06.2024Prairie Operating's Lee sold shares at $10.98-$12.85; new RSUs granted. Transactions disclosed via SEC Form 4. More details on T&C ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
Avidity Biosciences Director Sells $3.8M in Stockby Mark Eisenberg 15.06.2024Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...